112
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Clinical Evaluation of Active Tuberculosis-Related Deaths in Shenzhen, China: A Descriptive Study

ORCID Icon, , , , , & show all
Pages 237-242 | Published online: 22 Jan 2021

References

  • World Health Organization: Global Tuberculosis Programme. A Framework for Effective Tuberculosis Control. WHO/TB/94.179. Geneva, Switzerland: WHO; 1994.
  • World Health Organization: global tuberculosis report 2020. 2020.
  • Abouzeid MS, Al RF, Memish ZA. Mortality among tuberculosis patients in Saudi Arabia (2001–2010). Ann Saudi Med. 2013;33(3):247–252. doi:10.5144/0256-4947.2013.247
  • Zheng Z, Lin J, Lu Z, et al. Mortality risk in the population of HIV-positive individuals in Southern China: a cohort study. PLoS One. 2019;14(2):e0210856–e0210856. doi:10.1371/journal.pone.0210856
  • Henegar C, Behets F, Vanden Driessche K, et al. Mortality among tuberculosis patients in the Democratic Republic of Congo. Int J Tuberc Lung Dis. 2012;16(9):1199–1204. doi:10.5588/ijtld.11.0613
  • Aljadani R, Ahmed AE, Al-Jahdali H. Tuberculosis mortality and associated factors at King Abdulaziz Medical City Hospital. BMC Infect Dis. 2019;19(1):427. doi:10.1186/s12879-019-4063-7
  • Karthika M, Philip S, Prathibha MT, Varghese A, Rakesh PS. Why are people dying due to tuberculosis? A study from Alappuzha District, Kerala, India. Indian J Tuberc. 2019;66(4):443–447. doi:10.1016/j.ijtb.2018.05.001
  • Lin CH, Lin CJ, Kuo YW, et al. Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis. 2014;14(1):5. doi:10.1186/1471-2334-14-5
  • Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19(10):1129–1137. doi:10.1016/S1473-3099(19)30309-3
  • Pedrazzoli D, Kranzer K, Thomas HL, Lalor MK. Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data. ERJ Open Res. 2019;5(4):4. doi:10.1183/23120541.00125-2019
  • Horne DJ, Hubbard R, Narita M, Exarchos A, Park DR, Goss CH. Factors associated with mortality in patients with tuberculosis. BMC Infect Dis. 2010;10(1):258. doi:10.1186/1471-2334-10-258
  • Di Gennaro F, Vittozzi P, Gualano G, et al. Active pulmonary tuberculosis in elderly patients: a 2016–2019 retrospective analysis from an Italian Referral Hospital. Antibiotics (Basel). 2020;9(8):8. doi:10.3390/antibiotics9080489
  • The number of permanent residents of Shenzhen at the end of year. Available from: http://tjj.sz.gov.cn/ztzl/zt/sjfb/. Accessed January 12, 2021.
  • WHO documentation for World Health Assembly 67. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_11-en.pdf. Accessed January 12, 2021.
  • Shen X, Deriemer K, Yuan Z, et al. Deaths among tuberculosis cases in Shanghai, China: who is at risk? BMC Infect Dis. 2009;9(1):95. doi:10.1186/1471-2334-9-95
  • Bhering M, Duarte R, Kritski A. Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000–2016. PLoS One. 2019;14(11):e0218299. doi:10.1371/journal.pone.0218299
  • Di Gennaro F, Pizzol D, Cebola B, et al. Social determinants of therapy failure and multi drug resistance among people with tuberculosis: a review. Tuberculosis (Edinb). 2017;103:44–51. doi:10.1016/j.tube.2017.01.002
  • Nliwasa M, MacPherson P, Gupta-Wright A, et al. High HIV and active tuberculosis prevalence and increased mortality risk in adults with symptoms of TB: a systematic review and meta-analyses. J Int AIDS Soc. 2018;21(7):e25162. doi:10.1002/jia2.25162
  • Beijer U, Wolf A, Fazel S. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(11):859–870. doi:10.1016/S1473-3099(12)70177-9
  • Gao J, Zheng P, Fu H. Prevalence of TB/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS One. 2013;8(5):e64915. doi:10.1371/journal.pone.0064915
  • Hagan G, Nathani N. Clinical review: tuberculosis on the intensive care unit. Crit Care. 2013;17(5):240. doi:10.1186/cc12760
  • Duro RP, Figueiredo Dias P, Ferreira AA, et al. Severe tuberculosis requiring intensive care: a descriptive analysis. Crit Care Res Pract. 2017;2017:9535463. doi:10.1155/2017/9535463
  • Deng W, Yu M, Ma H, et al. Predictors and outcome of patients with acute respiratory distress syndrome caused by miliary tuberculosis: a retrospective study in Chongqing, China. BMC Infect Dis. 2012;12(1):121. doi:10.1186/1471-2334-12-121
  • Onyango DO, Yuen CM, Cain KP, Ngari F, Masini EO, Borgdorff MW. Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya. PLoS One. 2017;12(11):e0188235. doi:10.1371/journal.pone.0188235
  • Liu Y, Zheng Y, Chen J, et al. Tuberculosis-associated mortality and its risk factors in a district of Shanghai, China: a retrospective cohort study. Int J Tuberc Lung Dis. 2018;22(6):655–660. doi:10.5588/ijtld.17.0726
  • Kobashi Y, Matsushima T, Okimoto N, Hara Y. [Clinical evaluation of the cause of death in patients with active pulmonary tuberculosis]. Kekkaku: [Tuberculosis]. 2002;77(12):771–775. Japanese.
  • Barac A, Kosmidis C, Alastruey-Izquierdo A, Salzer HJF. Chronic pulmonary aspergillosis update: a year in review. Med Mycol. 2019;57(Supplement_2):S104–S109. doi:10.1093/mmy/myy070